There is increasing concern that patients with coronavirus disease 2019 (COVID-19) might
be at risk of developing invasive pulmonary aspergillosis co-infection. 1 In a cohort of 221 …

About 5% of patients with coronavirus disease 2019 (COVID-19) require intensive care unit
(ICU) management. 1 These patients are at high risk of developing secondary infections …

COVID-19–associated Pulmonary Aspergillosis | American Journal of Respiratory and Critical
Care Medicine ATS Journals Logo Official Publications of the American Thoracic Society Sign In …

Our report of two critically ill patients suggests that IPA might be a relevant complication of
severe COVID-19 pneumonia in analogy to experiences in severe influenza pneumonia …

Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes viral pneumonia
and can be complicated by acute respiratory distress syndrome (ARDS) which is similar to …

ABSTRACT COVID-19-associated pulmonary aspergillosis (CAPA) was recently reported as
a potential infective complication affecting critically ill patients with acute respiratory distress …

To date, COVID-19 has been pandemic across the whole world, whereas around 20% of
patients require treatment in intensive care units (ICUs)[1, 2]. However, the clinical …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report
a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA) …